DFID | iDSI https://www.idsihealth.org Better decisions. Better health. Tue, 25 Jun 2019 10:17:17 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.1 /wp-content/uploads/2019/04/favicon.png DFID | iDSI https://www.idsihealth.org 32 32 154166752 UHC Day 2017: The need for a sensible, fair and evidence based Health Benefits Package https://www.idsihealth.org/blog/uhc-day-2017-the-need-for-a-sensible-fair-and-evidence-based-health-benefits-package/ Fri, 15 Dec 2017 14:18:31 +0000 https://uat.idsihealth.org/?p=3282 The push for Universal Health Coverage (UHC) must focus on designing a Health Benefits Package that is sensible, fair and evidence based – this was the take-home message from IDSI’s visit to Washington DC this week.

The US capital was the setting for three days of meetings and events to mark UHC Day and the release of ‘What’s In, What’s Out: Designing Benefits for Universal Health Coverage’.

IDSI’s time in DC kicked off with a Global Health Initiatives meeting attended by representatives from the Gates Foundation, World Bank, Givewell, the Center for Global Development (CGD), PRICELESS South Africa, the UK Department for International Development (DFID), Clinton Health Access Initiative (CHAI), Japan International Cooperation Agency (JICA), the Joint Learning Network (JLN), Tufts Medical, Disease Control Priorities (DCP), the Health Intervention and Technology Assessment Program (HITAP), the Norwegian Institute of Public Health (NIPH) and Gavi the Vaccine Alliance.

During the meeting iDSI, CHAI, JLN, NIPH and Tufts Medical Centre showcased their initiatives and the concentration of their work including their successes, focus countries and potential future opportunities.

Amanda Glassman

Attendees then heard from Global Development Funders’ representatives: David Wilson from the Gates Foundation, Julia Watson from DFID, James Snowden from GiveWell, Adrien de Chaisemartin from Gavi, Naina Ahluwalia and Somil Nagpal from World Bank and Yosuke Kobayashi from JICA; with all agreeing each partner group is carrying out valuable efforts in the bid to expand and improve healthcare globally.

Tuesday 12 December was the celebration of UHC Day around the world. A sold-out event at the CGD offices saw presentations from iDSI Director Professor Kalipso Chalkidou, CGD Chief Operating Officer Amanda Glassman, Professor Karen Hofman from PRICELESS, Waranya Rattanavipapong from HITAP, iDSI Board chair Professor Tony Culyer and a keynote speech by Dr Mark McClellan.

Copies of ‘What’s In, What’s Out’ were available for attendees to take away and Amanda Glassman explained how the creation of an explicit health benefits plan is an essential element in creating a sustainable system of UHC. With limited healthcare budgets comes tough decisions for policymakers, along with the many facets of governance, institutions, methods, political economy and ethics that are needed to decide what’s in and what’s out in a way that is fair, evidence-based, and sustainable over time.

Dr Mark McClellan

At the heart of Dr Mark McClellan’s keynote address was opportunities for greater value for healthcare spending – specifically, the ‘accountable care’ model, which sees providers held jointly accountable for the cost and quality of care for a defined population of patients.

Dr McClellan, a doctor and economist, said: “There is more healthcare can do than ever before, however this means rising costs in healthcare. The value of healthcare can be improved by developing and implementing evidence-based policy solutions.”

The importance of sharing data and creating interoperability to understand health outcomes within an accountable care system was also put forward by Dr McClellan, who provided Nepal as an example of success in utilising remote personal health tools, telemedicine and lower-cost sites of care: “In Nepal a simple process of patients’ texting in information can result in a visit to their homes by community care workers and a potential prescription of antibiotics. Investment in these modest but effective interventions can also gather useful metrics in the form of electronic health records. We need to move from ‘siloed’ data to data that provides intelligence about our populations.”

Waranya Rattanavipapong

HITAP’s Waranya Rattanavipapong presented on building research capacity for UHC in Southeast Asia and told of how analysis by HITAP revealed Indonesia could save 90% of its insulin budget. Waranya said: “Indonesia has a current budget of $18 million per year for insulin. Tens of millions more than necessary is being spent on modern insulins to treat diabetes despite evidence cheaper products work just as well. Our analysis revealed switching from insulin analogue to human insulin and negotiating to Thai prices ($2 for human insulin and $9 for insulin analogue, compared to $20 for human insulin and $22 for insulin analogue in Indonesia) could save 90% of the budget.”

Professor Karen Hofman detailed the strides South Africa has taken towards promoting the health of the population by passing a bill to implement a tax on sugar-sweetened beverages. Professor Hofman, who proudly sported an ‘I am #sweetenough’ t-shirt supporting the sugar tax, focused on fiscal levers in South Africa and the positive impact they have had in the past: “After the increase in the excise tax on cigarettes, sales reduced between 1993-2009 by one third and per capita consumption decreased by 50%. With 25% of teenage girls in rural areas overweight in South Africa, the time is now for translating evidence on sugar to policy. There will inevitably be push-back from various sources but the passing of the bill, which will be implemented in April 2018, is a powerful step forward.”

Professor Karen Hofman

Professor Tony Culyer rounded up the event and took to the stage to emphasise iDSI’s objectives to help low- and middle-income countries to transition from aid, develop skills to spend smarter and to increase access to quality healthcare so they can achieve UHC: “Our aim is to give LMICs capacity to produce policies that will have an impact of health. We wish to leave behind an endowment of expertise for LMICs to build better worlds for themselves.”

A recording of the ‘Better Decisions, Better Health: Practical Experiences Supporting UHC from around the World’ event is available on the CGD website (1 hour 32 minutes).

UHC Day, commemorated each 12 December, is the anniversary of the first unanimous United Nations resolution calling for countries to provide affordable, quality healthcare to every person, everywhere. The United Nations Sustainable Development Goals, that all UN Member States have agreed to, try to achieve UHC by 2030. This includes financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.

Professor Tony Culyer

]]>
3282
Monitoring Value for Money of donor expenditure: learning lessons from the iDSI Reference Case https://www.idsihealth.org/blog/monitoring-value-for-money-of-donor-programme-expenditure-learning-lessons-from-the-reference-case-for-economic-evaluation/ Fri, 11 Mar 2016 15:13:07 +0000 https://uat.idsihealth.org//?p=1303 How do donors in international development make sure they are not wasting money? Doing so is harder than it may initially seem. Money is spent thousands of miles away from headquarters, in settings where information is poor, politics complex and staff turnover rapid. In practice, many use Value for Money (VfM) analysis to try and stay on top of this – generally based on a reasoned trade-off between economy, efficiency and effectiveness, sometimes taking into account equity and sustainability as well.

In a recent policy brief, Oxford Policy Management and the International Decision Support Initiative (iDSI) have asked “would the VfM analysis that the UK’s Department for International Development conduct on their programme expenditure be more useful if lessons were learnt from the iDSI Reference Case for Economic Evaluation?”. It is argued that significant methodological improvements are available to DFID – which could make the information they generate more useful for their decision makers. These recommendations are also applicable to other donors who follow similar guidelines for monitoring their VfM.

Alex Jones’ blog post exploring some of the issues raised in the brief is available on the Oxford Policy Management website.

 

]]>
1303
China: Nov 2012 – Sept 2015 https://www.idsihealth.org/blog/china-nov-2012-sept-2015/ Wed, 30 Sep 2015 15:00:03 +0000 https://uat.idsihealth.org//?p=1614 iDSI has been collaborating with China (through NICE International’s earlier engagements with CNHDRC) since 2012. See below for further information on events and work that took place between November 2012 and September 2015.

NICE signs MOU with CNHDRC during UK-China health talks

September 2015

NICE International developed and delivered a two-week study tour programme for a senior delegation from China.  We worked in collaboration with the British Embassy in Beijing and the UK Department of Health.

The study tour was organised as part of the People to People Dialogue (P2P), one of the UK’s key ministerial-level talks with China.

The delegation comprised 25 high level officials. The officials included seven division heads from the National Health and family Planning Commission (NHFPC) and the Director General of the CNHDRC (NICE International’s collaborator on the Clinical Pathways project.)

Director-General-Li-Tao-CNHDRC

Week 1 – Introduction to NICE and the NHS

The study tour began on the 9th September 2015, with representatives of the delegation receiving an introduction to the NHS and the work of NICE. Speakers included representatives from the Kings Fund (John Appleby and Chris Ham) and NICE (Kalipso Chalkidou, Francis Ruiz and Sir Andrew Dillon).

The delegation visited the Royal London Hospital where Professors Tony Rudd and Mike Roberts gave presentations on UK stroke services and COPD management (areas covered by the ongoing Clinical Pathways project). The presentations emphasised the need for better integration and innovation at different levels of the health system. Professors Rudd and Roberts also stressed the importance of evidence informed guidance to support practice change and guide monitoring and performance improvement.

Later during the first week the delegation visited the King’s Health Partners. The visit helped to reinforce issues related to better coordination between healthcare providers and academia and the importance of supporting research excellence directly aligned with improving patient care.

It was noted that institutions such as NICE have a key role in supporting the translation of research evidence into policy recommendations that can feed into actual practice change.

The end of the first week culminated with a visit to the Department of Health. The delegation was given an overview of the UK NHS, the approach to branded pharmaceutical pricing and the work being undertaken on Global Health Security. There was a focus on the enormous challenge presented by antimicrobial resistance (AMR).

Week 2 – visits, MOU and panel discussion

The second week of the study tour involved:

  • a visit to the Health and Social Care Information Centre in Leeds,
  • a presentation from Professor Andrew Stevens on the experience of being a Chair of a NICE Technology Appraisals committee
  • a session on the role of the NIHR Horizon Scanning Centre, based at the University of Birmingham.
  • and a talk from of the Association of the British Pharmaceutical Industry.

Chinese-health-delegation-NIHR-Horizon-Scanning-Centre

UK – China health dialogue

A key highlight of the second week was the UK-China Health Dialogue that took place in the historic environment of the Royal College of Surgeons in Lincoln’s Inn Fields, London.

Keynote speeches were delivered by:

  • Liu Yandong, Vice Premier of China,
  • the Rt. Hon Jeremy Hunt MP,
  • Margaret Chan, Director-General of the World Health Organisation.

All the speakers noted the mutual and international benefits following from greater UK-China cooperation in health.

Vice Premier Liu Yandong noted that other countries including China wished to learn from the “British model” of healthcare funding and provision, whilst highlighting the importance of finding “Chinese solutions” to health system reform.

Margaret Chan highlighted the issue of AMR, noting that the UK and China could work together to identify a multi sectoral approach to this challenge, which also has policy coherence.

Jeremy Hunt made reference to examples of important UK-China partnerships in health including the relationship between NICE International and CNHDRC. He noted that NICE and the CNHDRC had agreed a new Memorandum of Understanding (MOU) during this P2P for further cooperation in areas of evidence informed policy making.

Memorandum of understanding

The MOU between NICE and CNHDRC builds on the successful collaboration between NICE International and CNHDRC in the area of clinical pathways.

Spanning five years, the MOU details the process, methods and research needed to develop clinical guidelines and quality standards in China.

Under the MOU, NICE International will provide technical help on the development of frameworks that will lead to locally relevant and locally owned clinical guidelines and quality standards.

The collaborative project will pilot work in conditions selected as high priority, which have a high disease and economic burden. AMR, drawing on NICE’s recent (2015) stewardship guidelines, will be considered for the pilot.

The MOU was signed by Li Tao, Director General of CNHDRC and Sir Andrew Dillon, CEO of NICE.

Panel session

The Health Dialogue culminated in a panel session moderated by the UK’s Chief Medical Officer, Professor Dame Sally Davies.

The panellists were:

  • Director General Li Tao (CNHDRC),
  • Director General Zhang Zongjiu of the Bureau of Medical Administration (NHFPC),
  • Kalipso Chalkidou of NICE International
  • Lord Jim O’Neill, Commercial Secretary to the UK Treasury and chair of a review into AMR.

Both DG Li Tao and DG Zhang Zongjiu highlighted their key observations from the study tour. They referenced the role of NICE in the UK and their ambition to work with NICE through its international unit to establish a similar priority setting institution in China.

DG Li Tao wished to deepen the existing collaboration with NICE International, through iDSI to develop health technology assessment in China.

 

NICE International holds final discussions with CNHDRC ahead of Clinical Pathways dissemination event in October

July 2015

Francis Ruiz and Laura Morris travelled to Beijing in July 2015 as part of the continuing collaboration with the China National Health and Development Research Centre (CNHDRC). The CNHDRC is a think tank of the National Health and Family Planning Commission, the former Ministry of Health.

The aim of the July visit was to meet with researchers at CNHDRC to discuss the analytical work to date on the Clinical Pathways project (Phase 2), with its focus on managing COPD and stroke. Participants at the meeting also discussed preparations for a major meeting planned for October 2015. This meeting will involve key stakeholders and participants in the pathways project, including administrators and clinicians from the implementing hospitals at four sites in rural China.

The October event will include the launch of a book (in both Chinese and English) describing the clinical pathways project, the NICE International-CNHDRC collaboration and the methods for devising the clinical pathways, which involved both Chinese and international experts who partnered with NICE International on the project.

The book will also present the quantitative and qualitative findings from an analysis of the impact of introducing the pathways with payment reform in the participating study hospitals. This analysis was the focus of the project meetings in July, where participants discussed the statistical approaches used to look at before-and-after comparisons of key indicators and the identification of appropriate quality measures.

 

NICE International visit China with Indian colleagues

March 2015

As part of an on-going collaboration with the Center for Health Policy and Technology Assessment, a division of the China National Health Development Research Center (CNHDRC), NICE International representatives travelled to China to discuss latest developments on the “Clinical Pathways Phase 2” project. In addition, two colleagues from India joined the discussions and also participated in a visit to a project study site in Qianjiang. Dr Nagesh Prabhu (Joint secretary, Department of Health Research, Minister of State for Health & Family Welfare) and Dr. Raju Sukumaran (Medical officer, Comprehensive Health Insurance Agency, Kerala) were provided an overview of the collaboration between NICE International and CNHDRC, that included a description of the work done during Phase 1 with its focus on developing evidence informed surgical pathways linked with payment reform.

The clinical pathways developed as part of Phases 1 and 2 are one component of a multi-faceted and complex intervention that has included capacity building, multi-stakeholder engagement, and changes in IT infrastructure and performance management strategy within the study hospitals.  Notably, Phase 2, with its emphasis on pathways for non-communicable disease (stroke and COPD) has also facilitated efforts for improving integrated care across multiple tiers in the rural health system. This is strongly exemplified by Qiangjiang hospital, which under the leadership of Mr Liu, has worked to develop effective referral pathways and closer links with township health centres as part of Phase 2 pathway implementation. This strengthening of links across multiple tiers has also benefited from the use of technologies such as telemedicine which allows Qianjiang hospital experts to provide diagnostic and care support to township health centres thereby reducing the need for patients to travel.

Drs Prabhu and Sukumaran noted that a key feature of the pathways project has been the apparent success associated with its implementation, including the importance of stakeholder buy-in and local leadership to support behaviour change. CNHDRC has worked intensively with each study site in developing the pathways and getting them integrated within hospital IT systems.

CNHDRC representatives plan to further share their findings during a dissemination visit to India later in 2015. This will also provide an opportunity both Indian and Chinese colleagues to share their experiences and support the further institutionalisation of  evidence-informed decision making.

NICEInternational-visit-China-with-Indian-colleagues

NICE International visit China to provide support to colleagues in pilot counties

November 2014

Between 23 and 28 November 2014, NICE International visited China, to provide support to our counterparts, the China National Development and Research Centre and our county level colleagues in select pilot counties, to adapt and implement Clinical Pathways for high burden chronic diseases, such as stroke and COPD.

The trip was funded by the FCO’s Prosperity Fund and DFID UK, and the team included Professor Martin McShane, head of long term conditions for NHS England and a GP, Professor John Appleby, Chief Economist of the King’s Fund and Dr Kalipso Chalkidou, Director of NICE International.

The visit highlighted the challenges the Chinese and English systems share, including managing performance, measuring quality and ensuring payment incentives are aligned with the system’s objectives; care integration and care coordination across tiers and settings and gaining professional and patient buy-in during the reforms.

The team visited two rural counties in Eastern China and one city:

Donghai county, Jiangsu province

Donghai county is initiating an integrated care pilot supported by the FCO, aiming at streamlining referrals between county hospitals, township clinics and village clinics.

We met with heath authorities and hospital management of the local county and township hospitals as well as a village clinic and were introduced to the telemedicine infrastructure which allows professionals at different tiers to interact with one another – facilitating referrals and coordinated care.

NICE-International-Donghai-county-visit

Jiaonan county, Shandong province

Jiaonan county has been working with NICE and CNHDRC under the DFID project of clinical pathways for NCDs since 2013, with an emphasis on stroke and COPD, major drivers of disease burden in the county.

In Jiaonan, we visited the new county hospital (600 beds) including a dedicated stroke ward. We heard about the progress of the pilot, including the collection of patient reported outcome measures using EQ-5D, and the implementation of payment reform to encourage participation of patients to the Clinical Pathway.

The Clinical Pathway, in addition to introducing standardised management of NCDs, emphasises the importance of secondary prevention (e.g. continuous management of risk factors at village and township level post-discharge) and also rehabilitation and patient education, and seeks to align payment to ensure the above are implemented.

Qingdao city, Shandong province

A city of 8 million peopple in a special growth zone, which launched, during our visit, a clinical pathways pilot on stroke with a view to emulating, in parallel to the pilot, the reconfiguration of stroke services in London.

We have been working with Qingdao for over a year, with support from Professor Tony Rudd, national director for stroke for NHS England, and signed an MoU earlier this year to support the City with its healthcare reforms. Qingdao’s pilot involves both the health and social security authorities, representatives of both being present at the launch, and it’s Chinese component is funded by the municipality.

 

Qingdao Health Bureau and NICE sign a Memorandum of Understanding

February 2014

The Head of the Qingdao Health Bureau, Mr Cao Yong and the Deputy Chief Executive of NICE, Dr Gill Leng, signed a Memorandum of Understanding between the two organisations. The aim of the MoU is to enhance collaboration and two way learning with a particular focus on NICE’s Approach to technology assessment and quality improvement in the field of non-communicable diseases. The ceremony was held at the Foreign and Commonwealth Offices in London and witnessed by the Chinese Vice Minister of health Mr Chen and the British Public Health Minister Jane Ellison. Qingdao is a major city in eastern China, with a population of over 8 million and one of the fastest rates of economic growth across Chinese cities and this is the first MoU between NICE and the health authorities of a major city overseas.

We look forward to working with the Qingdao authorities, with support from our partners in China, the China National Health and Development Research Centre, to promote quality and efficiency in health and we hope this partnership will serve as a model for other Chinese cities.

NICE and CNHDRC facilitated an introduction between the Qingdao health authorities and NHS London which also signed a bilateral agreement. This follows on from a NICE mission to Qingdao, in the spring of 2013, during which Professor Tony Rudd discussed with Qingdao officials the success of the London reconfiguration of stroke services, a project the Chinese colleagues felt would be relevant and useful to their own setting.

Following the signing, the Ministerial and Qingdao delegations visited NICE as well as other NHS organisations, including the Riverside Medical Centre at Vauxhall, the Waldron GP Walk in Centre in Lewisham, the Hurley Clinic in Kennington and St. Thomas’s Hospital.

Pilot project in China

The China National Health Development and Research Centre (CNHDRC) in collaboration with NICE International have embarked on a pilot project involving the design and implementation of evidence informed pathways of care, linked with payment reform with an emphasis on integrated care, for two high priority disease areas (chronic obstructive pulmonary disease [COPD] and stroke). This builds on the initial (Phase I) ‘Clinical Pathways’ (CP) project associated with the Health XI initiative and initiated in 2009, with WB, DFID China an DFID UK support.

The development of these pathways for this high burden diseases involves iterative input from experts in China and the UK, and are based on existing management strategies in the pilot counties. As part of this iterative exchange, in June 2013, a visit was made by NICE International experts and a Chinese-led team (including the Director of Qianjiang Central hospital of Chongqing city which was involved in the Phase I project) to two of the four counties selected for participation in Phase II (Wen county and Jiaonan county). The visit included dedicated sessions with relevant hospital staff to provide feedback on current practice and the draft clinical pathways on stroke and COPD.

The choice of stroke and COPD as topics for pathway development requires a consideration of how multiple tiers within the existing health system interact and cooperate. Consequently the visit to the provinces additionally included exposure to township hospitals and village health centres to understand existing facilities, patterns of working, and opportunities for vertical cooperation. In addition, the clinical pathways will be developed in such a way as to facilitate their full incorporation within existing provider IT systems. This visit therefore also included a brief assessment of IT facilities specifically in relation to supporting the objectives of CP implementation.

The NICE International and the Chinese-CNHRC delegation met with senior hospital and health centre staff, and also officials from the local health bureau. There was acknowledgement from the pilot sites and local policy makers of the importance of evidence-based practice and the development of quality indicators alongside payment reform.

Further Information

The Chairman of NICE and the Director of NICE International spent a few days in Beijing meeting with NICE’s major partners in China and publicising NICE’s work in the rural health reforms.

September 2013

The meetings included a day-long meeting at Renmin University, the fifth annual bilateral conference between NICE and Renmin, which, this year, was focused on care quality, hospital reform and the role of integrated care, including primary care. The conference, hosted by Renmin, one of the most prestigious and oldest universities in China, with a track record in social sciences and health policy in particular, was attended by over 100 colleagues from across China, including the Beijing and Shanghai Health Bureaus, the newly formed National Health and Family Planning Commission (NHFPC), the Ministry of Human Resources and Social Security, as well as officials from the provinces, academics and hospital administrators. We look forward to continuing and intensifying our partnership with Renmin in the coming year.

On the second day of our visit we met with senior officials from the World Bank and with our long-term partners in China, the think tank of the ministry of health, the China National Health and Development Research Centre (CNHDRC). We discussed progress with implementation of our NCD clinical pathways across four rural pilot counties and plans for scaling the pilots up.

On day three we had the honour of meeting, together with CNHDRC, the Director General of Planning and Information, a new division at the NHFPC, with her colleagues, including the officer leading on the design of the 13th 5-year strategic Plan and the Head of international affairs for Europe and North America. All three sides reiterated their commitment to working together, emphasising the need to improve efficient resource allocation at the micro/technology and macro/service delivery levels, and the importance of good quality community/primary care as the only means of achieving sustainable universal coverage.

This meeting was followed by a high level session with Vice Minister Ma where the Vice Minister called for NICE to continue and intensify its involvement in the Chinese health reforms, incl. urban health reforms, public hospital reforms incl. referral pathways and integration between prevention and treatment, and low and high tier hospitals. The Minister called for a strategic partnership between NICE, the Ministry and CNHDRC for institutionalising a Chinese model of Health Technology Assessment to meet China’s needs.

The second half of the day was spent at the Development Research Commission, the prestigious think-tank of the State Council, the Chinese equivalent of the Cabinet Office. The session was attended by colleagues from the National Development and Reform Commission, the NHFPC and different DRC divisions, and was supported by the British Embassy in Beijing. NICE offered to work with DRC in their research on HTA and quality standards and how these notions relate to the ongoing Chinese health reforms.

China EQ-5D workshop

November 2012

The EuroQol Group, in partnership with NICE International, delivered a one-day workshop on the EQ-5D to researchers and officials from the China National Health Development Research Center (CNHDRC) and academics from Beijing and Nanjing, among others.

The EuroQol speakers were: Professor Nancy J. Devlin, Director of Research, Office of Health Economics, London and Chair of the EuroQol Group Executive Committee; and Professor Jan van Busschbach; Director of the Department for Medical Psychology and Psychotherapy, Erasmus University and Chair of the EuroQol Group Board. The workshop was co-chaired by Francis Ruiz of NICE International and Professor Zhao Kun from the CNHDRC, Division of Health Policy Evaluation and Health Technology Assessment.

The topics covered included: origins of the EQ-5D, the recent development of the five-level version, and the use of EQ-5D in decision making and in health service performance management (the UK PROMs programme). One important area of discussion among all participants related to the availability of appropriate Chinese value-sets for the EQ-5D (three-level and five-level) and potential further research opportunities.

Clinical pathways and payment reform project launched in China

November 6-7, 2012

China National Health Development Research Center (CNHDRC) and NICE International launched their collaboration project on implementing evidence informed clinical pathways in China.

The two-day event was titled “Strengthening evidence-based policy making to achieve universal healthcare: Clinical pathways and payment reform in China and its dissemination”, and included participation from local and national policy makers (Ministry of Health, Ministry of Commerce, Ministry of Finance, the National Development and Reform Commission, among others), representatives from rural county hospitals implementing the pathways, and foreign experts from the UK, India, Nepal and the Netherlands. Also in attendance were members of the British Department for International Development (DFID) China. The conference was supported by the Chinese Ministry of Health and DFID.

Attendees heard details of the clinical pathways project and discussed evidence-based management of patients with Chronic obstructive pulmonary disease (COPD) and stroke, the chosen areas for Chinese pathway development. In addition, there were presentations from representatives from India (the Head of Audit for the Aarogyasri Scheme of the State of Andra Pradesh, and a representative of the Department of Health Services and the National Rural Health Mission in Kerala) and also from Nepal (a senior clinician and researcher and his Excellency, the Ambassador of Nepal in Beijing). Attendees at the conference also heard from a representative of PharmAccess, a Dutch NGO with a significant track record in Africa.

The two-day conference was followed by a meeting at CNHDRC offices to discuss potential mutual learning projects between China and other countries, in the framework of ‘South-South’ collaboration.

In March 2013, Health Affairs published a report on the clinical pathways pilots in rural China aiming at improving quality and efficiency in a series of high burden chronic diseases, with support from NICE 

]]>
1614
Institutional strengthening in health: Lunch seminar at the Department for International Development https://www.idsihealth.org/blog/institutional-strengthening-in-health-lunch-seminar-at-the-department-for-international-development/ Mon, 24 Aug 2015 14:07:17 +0000 https://uat.idsihealth.org//?p=1826 NICE International were invited to speak at the Department for International Development (DFID) “brown bag” lunch seminar, discussing issues in international health with DFID Health Advisers. Dr Ryan Li and Laura Morris, in conjunction with Rob Lloyd, Itad (our partners on monitoring and evaluation), presented our approach to institutional strengthening.

The discussions focused on our practical support to decision makers in Kerala (India) and China, funded by the Health Partnership Scheme. We have worked on request with government institutions to implement quality improvement in maternal health and the management of non-communicable diseases. The field reviews and key stakeholder interviews conducted by Itad emphasised the value of the ‘NICE brand’, and of our power in convening policymakers, healthcare providers and clinicians in joint-working to develop locally-owned, sustainable, and transparent processes for priority-setting.

For supporting countries that are aspiring towards universal health coverage, the NICE International approach may be a useful model for laying down some of the important institutional foundations of health systems strengthening. Dr Francoise Cluzeau, Associate Director of NICE International, will be returning to the DFID lunch seminar series in April to discuss in-depth the impact of our ongoing engagements at state and central levels in India.

Itad’s report on NICE International’s engagement in India, which explores the findings in more detail, has now been published online and is available here. NICE International and Itad are collaborating to build a robust M&E framework for the International Decision Support Initiative, to understand and share lessons on our role in institutional strengthening in low and middle-income countries.

Find the presentation here 

]]>
1826
Cuba https://www.idsihealth.org/blog/cuba/ Tue, 30 Jun 2015 14:26:21 +0000 https://uat.idsihealth.org//?p=1610 Learning from the Cuban experience in medical education

April 2017

Members of a collaborative Cuba-UK-South Africa project exploring the value of Cuban-training for South African medical students met this year to discuss how the programme can promote Universal Health Coverage (UHC).

The ‘South Africa-Cuba doctors programme’, which offers bursaries to South Africans from disadvantaged backgrounds to study medicine in Cuba as part of a deal struck by Fidel Castro and Nelson Mandela two decades ago, was the subject of a Department for International Development funded policy research project, which included researchers from London School of Hygiene and Tropical Medicine (LSHTM), Imperial College London, Public Health England and the Human Sciences Research Council (HSRC), South Africa.

The large number of Cuban-trained South African would-be doctors returning to work in South Africa (600-900 medical students return each year) are a major resource with the potential to re-engineer South Africa’s primary healthcare system to focus on preventive care and promote UHC. The researchers noted this was especially advantageous as they found few South African-trained doctors wish to make a career in family medicine (general practice). Therefore, improving the quality and quantity of family physicians (GPs) is critical for South Africa to achieve UHC. Returning trained doctors from the programme plug some of this gap as they go on to work as doctors in the public sector; they are also more likely to work in underserved areas that they come from long-term.

A major recommendation of the project was for improved support and re-integration of the doctors trained in Cuba upon their return to South Africa. Returning students must undergo up to three years of additional training to ensure they have experience of diseases such as HIV/AIDS, TB and malaria, which no longer exist in Cuba. As a result, some of them effectively return to train as 3rd year medical students, despite their six years of training in Cuba.

The research also found that students experience personal, academic and structural challenges when they return to study in South African medical schools. Duration and content of orientation programmes differed between the schools; language difficulties made studying difficult (Cuban-trained students spend their first year on premedical bridging training and become proficient in Spanish) and cultural adjustment after six years away was needed. Findings also indicated returning students had to adapt to more hospital and ‘rescue’ medicine emphases; and experienced difficulties with an unfamiliar exam system.

Further recommendations included: more systematic collection of data on both Cuban- and South African- trained cohorts to enable monitoring of careers pathways and relevance to South Africa’s needs; investment of new resources based in rural and urban underserved areas for medical training in South Africa; and for future research to focus on the political economy of medical education to understand the challenges, agents for change and examples of success that can be expanded.

The end-of-project meeting, which took place in April 2017, was attended by representatives from Imperial College, LSHTM, Public Health England, the Royal College of General Practitioners, Tropical Health & Education Trust (UK), HSRC, Medical Executive Committee for Health (South Africa), Cuban-trained doctors returned to South Africa from the University of Cape Town and Cuban representatives from the Ministry of Health, the Pan American Health Organization. Read the meeting agendafull meeting report, a longer blog (at project end) by Shah Ebrahimview key presentation slides; and watch video interviews with Dr SM Dhlomo, the Member of the Executive Council for Health in KwaZulu-Natal, South Africa and a medical student from the South Africa-Cuba doctors programme. 

NICE International co-hosts Cuba medical education workshop in Pretoria 

June 2015

At the end of June 2015, NICE International participated as a co-organiser with London School of Hygiene and Tropical Medicine (LSHTM), Public Health England (PHE) and the Human Sciences Research Council (HSRC) of South Africa in a two-day conference in Pretoria, about the value of Cuban medical training to the South African setting, as part of the DFID funded project.

With support from HSRC and LSHTM, NICE International will be carrying out a health technology assessment of alternative training models with a view to drawing lessons for primary care transformation models in Sub Saharan Africa, but also in countries like the UK, which are facing a crisis with regard to human resources for primary care.

Read more about the event in Shah Ebrahim’s blog, and read more about the project in the concept note submitted to Ministry officials in Cuba and Republic of South Africa, and the case study prepared for UN High Level Commission on Health Employment and Economic Growth.

Panel discussion event at the house of Lords

March 2015

On the 4 March 2015, NICE International, Public Health England and the London School of Hygiene and Tropical Medicine held a panel discussion event at the House of Lords.

The discussion looked at the ‘Potential Lessons for Primary Care Emerging from the Cuban Model of Medical Education’. The event was hosted by the All Party Parliamentary Group on Global Health and Chaired by Lord Crisp. Speakers included representatives from the Pan American Health Organisation, the Faculty of Public Health, the World Health Organisation and the Embassy of the Republic of Cuba.

The event highlighted the Cuban approach to medical education and looked at research being undertaken to test how effective this approach is. The event also looked at how transferable the Cuban model could be into other contexts. Contrasting views of the successes of the Cuban model were shown in two video presentations shown at the event. The presentations stimulated audience discussion around the future development of primary care and medical education in the UK.

The discussions will be used to inform the ongoing project exploring the applicability of the Cuban model to other settings.

Read more in Professor Shah Ebrahim’s blog post about the event.

Scoping visit to Havana

October 2014

A team from NICE International (Kalipso Chalkidou), LSHTM (Shah Ebrahim) and Public Health England (Neil Squires) (formerly DFID), visited Havana to scope out the joint project on the Cuban model of medical education for Africa. The project is being run by NICE, PAHO, LSHTM and the Cuban MoH.

The team also participated in the 2nd International Conference on Medical Education for the 21st Century organised by the Cuban Ministry of Public Health. The Conference was attended by over 400 people from several countries including Angola and Latin America. Over three days, the conference explored the direction of travel in modern medical education in light of countries’ commitments to Universal Healthcare Coverage and of emerging challenges of chronic diseases and increasing financial pressures on limited budgets.

Dr Neil Squires gave a plenary address during which he highlighted the importance of publicising the lessons of the Cuban medical education model, supported by evidence of its effectiveness and cost-effectiveness, and using these lessons to influence the ongoing consultation by WHO on a longer term global healthcare workforce strategy.

During a whole day side event organised by the Ministry, the UK team had the opportunity to connect with major stakeholders in Cuba including the Rector of the Latin American University, senior professors including the vice president of the University of Havana’s Medical University, the secretary of the Cuban university accreditation board, the CEO of THEnet, the Director of the Cuban School of Public Health, members of the Board of and the CEO of MEDICC, senior MINSAP officials including Dr Ileana Morales, the President of the Conference, and PAHO, including the Director of the country office. The discussion explored the research proposal which recently gained approval from DFID, its policy implications and practical ways for taking the work forward incl. major partners in Cuba and in Arica.

In addition, the UK team had working meetings with PAHO and visited the British Ambassador in Cuba who has been supporting the DFID funded work since its launch.

NICE/LSHTM/PHE will work with their Cuban counterparts and African researchers to modify the research protocol, assign research tasks and organise additional field visits to Cuba and Africa over the next 12 months, with a view to using it research findings to influence the ongoing consultation on the WHO’s Human Resources for Health Strategy, due to report in 2016, but also with the aim of further publicising the attributes of the primary care-focused Cuban model and its potential relevance for the UK setting.

NICE International visited Cuba to scope out partnerships on policy and research

November 2013

This is the second visit, following summer 2013, when we visited supported by the Rockefeller Foundation, to take part in a Lancet organised event on learning lessons from the history and evolution of Latin American and Caribbean healthcare systems.

With support from the PAHO country office, the NICE chairman, Professor David Haslam, the director of NICE International Kalipso Chalkidou, and Professor Shah Ebrahim of LSHTM and an honorary NHS consultant with NICE, spent 3 days meeting senior academic colleagues, including professors and deans of the National School of Public Health, the Cuban Medical University of Havana, the Cuban International Cooperation Centre, managing the Cuban Medical Missions overseas, as well as officials from the MoH, including the Vice Minister and Centro Nacional Coordinador de Ensayos Clínicos (CENCEC), the clinical trials regulatory authority of Cuba. INFOMED, the medical electronic portal of Cuba, and Escuela Latinoamericana de Medicina(ELAM), the Latin American Medical University training overseas students from LAC, Asia and Africa, where also part of the visit. Finally, they had the chance to meet the British Ambassador in Havana.

NICE International, with its academic partners in the UK, will be looking to engage in a collaborative research project with the Cuban academics to assess the primary care and prevention focused model of medical education of Cuba in the context of Sub Saharan Africa.

Cuba maintains medical missions in over 60 countries around the world, working in emergency situations or in remote rural areas and is in parallel, training – mostly for free – thousands of doctors in Cuba or Cuban Universities overseas.

Another aspect of our partnership could focus on methods for developing and implementing clinical guidelines and HTA with an emphasis on quality and efficiency, taking a whole system (as opposed to a technology focused) approach. Options for partnering up with LSHTM and with the Public Health Foundation of India, were also discussed.

NICE International visits Cuba to take part in the Lancet meeting on universal health coverage

July 2013

Kalipso Chalkidou, Director of NICE International visited Cuba to take part in the Lancet meeting on universal health coverage (UHC) in the Latin American countries (LAC), with support from the Rockefeller Foundation. Cuba has a primary care focused healthcare system, which ranks highly globally in terms of access, quality and health outcomes and efficiency.

During the short visit, Kalipso met colleagues from:

  • government
  • the regulators
  • universities
  • non-government organisations
  • Pan American Health Organization (PAHO), including the Director of PAHO, Dr Carissa Etienne.

There is a joint commitment for PAHO, NICE and Rockefeller, working together on priority setting for UHC and on sharing the knowledge and experiences (good and bad) of the LAC region with other countries transitioning towards UHC. We will work together with other partners such as the Department for international development (DFID) and the World Bank, to set out specific actions we can carry out together, in accordance to the strategic priorities of PAHO and the countries in the region and with an emphasis on catalysing South-South partnerships with countries in LAC but also sub-Saharan Africa.

The visit offered the opportunity to meet the Minister of Health of Cuba and his vice ministers, including the vice minister responsible for international cooperation with whom, along with the PAHO lead and the Director for International cooperation, Kalipso discussed opportunities for partnerships and sharing our system’s experience, and for working on a tripartite basis in countries where Cuba supports human resources and medical education and NICE offers technical assistance for strengthening priority setting processes and technology evaluation.

Finally, Kalipso visited the Cuba neuroscience centre, which concentrates on developing high value low cost diagnostic, screening and management technologies for high priority diseases and conditions, to serve the needs of the Cuban population. The Centre also exports technologies and healthcare solutions (e.g. screening policies for hearing impairment and learning difficulties in young children) around the world.

There was broad agreement as to the potential for partnership up with the Cuban Ministry of Health and sharing experiences with countries in the region and beyond. NICE International will work with PAHO, Rockefeller and also with the Ministry of Health of Cuba and the UK’s DFID to scope out potential joint projects especially on capacity building for UHC in sub-Saharan African countries.

]]>
1610